Weiguo Su

Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)

Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology

Macrophages in immunoregulation and therapeutics

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

Artificial intelligence in radiology

Applications of Deuterium in Medicinal Chemistry

The Catalytic Asymmetric Intermolecular Prins Reaction

Artificial intelligence in cancer imaging: Clinical challenges and applications

Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal–Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer

Summation of F18-FDG Uptakes on PET/CT Images Predicts Disease Progression in Non-small Cell Lung Cancer

Phase II study of savolitinib in patients (pts) with pulmonary sarcomatoid carcinoma (PSC) and other types of non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations (METex14+).